Checkpoint Surgical

Checkpoint Surgical

Checkpoint | Handheld Intra-Operative Nerve Stimulator/Locator. Learn more
  • Edit
DateInvestorsAmountRound

$1.1m

Series A

$250k

Series A

$1.7m

Series B
N/A

$7.5m

Series B

$7.5m

Series C

$8.8m

Series D

$16.0m

Late VC
Total Funding€39.0m

Recent News about Checkpoint Surgical

Edit
More about Checkpoint Surgicalinfo icon
Edit

Checkpoint Surgical is a medical device company specializing in advanced nerve care solutions. The company operates in the healthcare market, focusing on providing innovative products for nerve protection and repair. Checkpoint Surgical serves surgeons and healthcare professionals who perform nerve-related surgeries, including procedures like Targeted Muscle Reinnervation (TMR) for amputees. The company's business model revolves around the development, manufacturing, and sale of specialized surgical instruments and biomaterials. Revenue is generated through the direct sale of these products to hospitals, clinics, and surgical centers. Checkpoint Surgical's flagship products include the CHECKPOINT Nerve Cutting Kit, which helps preserve tissue integrity during nerve repair, and the CHECKPOINT NEUROSHIELD, a biomaterial made from chitosan designed to optimize nerve repair. The company is committed to advancing the understanding of peripheral nerve function and recovery by collaborating with leading surgeons and researchers. Recently, Checkpoint Surgical announced the addition of 18 new jobs at its headquarters in Highland Hills, Ohio, supported by an Ohio Job Creation Tax Credit. The company also underwent organizational changes to support its rapid growth in the nerve care market, with Len Cosentino transitioning from President and CEO to Founder and Executive Advisor.

Keywords: nerve care, surgical instruments, biomaterials, nerve protection, nerve repair, healthcare, TMR, chitosan, medical devices, surgeon collaboration.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Checkpoint Surgical

Edit
Monarch Bioimplants
ACQUISITION by Checkpoint Surgical Aug 2021